BioWorld Today: News to Note - ChemGenex Pharmaceuticals

April 14, 2011

Cephalon Inc., of Frazer, Pa., lodged the offer document for its A70 cents per share (US74 cents), or about $225 million, for ChemGenex Pharmaceuticals Ltd., of Melbourne, Australia, with the Australian Securities and Investments Commission. The bidder’s statement is expected to be dispatched to ChemGenex shareholders April 18, and the offer period is set to close on May 23. (See BioWorld Today, March 30, 2011.)